Luye Pharma Group Ltd (LUP) - Total Liabilities

Latest as of December 2025: €14.47 Billion EUR ≈ $16.91 Billion USD

Based on the latest financial reports, Luye Pharma Group Ltd (LUP) has total liabilities worth €14.47 Billion EUR (≈ $16.91 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Luye Pharma Group Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Luye Pharma Group Ltd's total liabilities have evolved over time, based on quarterly financial data. See LUP net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Luye Pharma Group Ltd Competitors by Total Liabilities

The table below lists competitors of Luye Pharma Group Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Inrom Construction Industries Ltd TA:INRM	Israel	ILA830.76 Million
Shenzhen Minkave Technology Co Ltd SHE:300506	China	CN¥152.59 Million
TravelSky Technology Limited F:TVL	Germany	€8.57 Billion
Shenzhen Liande Automatic Equipment Co Ltd SHE:300545	China	CN¥806.34 Million
Shanghai Diesel Engine Co Ltd A SHG:600841	China	CN¥10.14 Billion
Ji'an Mankun Technology Co. Ltd. A SHE:301132	China	CN¥1.16 Billion
Inversiones Aguas Metropolitanas SA SN:IAM	Chile	CL$1.80 Trillion
Nobia AB ST:NOBI	Sweden	Skr8.09 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Luye Pharma Group Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Luye Pharma Group Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.90	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Luye Pharma Group Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Luye Pharma Group Ltd (2016–2025)

The table below shows the annual total liabilities of Luye Pharma Group Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€14.47 Billion ≈ $16.91 Billion	+4.39%
2024-12-31	€13.86 Billion ≈ $16.20 Billion	+15.85%
2023-12-31	€11.96 Billion ≈ $13.99 Billion	-9.43%
2022-12-31	€13.21 Billion ≈ $15.44 Billion	-1.93%
2021-12-31	€13.47 Billion ≈ $15.75 Billion	+7.47%
2020-12-31	€12.53 Billion ≈ $14.65 Billion	+26.05%
2019-12-31	€9.94 Billion ≈ $11.62 Billion	+3.51%
2018-12-31	€9.60 Billion ≈ $11.23 Billion	+148.54%
2017-12-31	€3.86 Billion ≈ $4.52 Billion	+46.17%
2016-12-31	€2.64 Billion ≈ $3.09 Billion	--

About Luye Pharma Group Ltd

F:LUP Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.02 Billion

€870.80 Million EUR

Market Cap Rank

#8996 Global

#1142 in Germany

Share Price

€0.22

Change (1 day)

+2.83%

52-Week Range

€0.19 - €0.48

All Time High

€0.70